HP moves into life sciences, while microfluidics market sees a surge in patent filings and suits
A new analysis of the thriving synthetic biology patent landscape has revealed the top patent owners and dealmakers in this space, as well as those appearing most often in the courtroom. Among its key findings are that Hewlett Packard (HP) has…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.